Skip to main content

Table 5 Number of oocytes retrieved and embryo assessment

From: Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis

Variables

r-FSH/r-LH

r-FSH

p

No. of cycles

884

2652

 

Oocyte retrieval

10.00 (7.00, 14.00)

12.00 (7.00, 17.00)

 < 0.001

IVF 2PN number

7.00 (4.00, 10.00)

7.00 (4.00, 11.00)

0.572

IVF 2PN rate (%)

90.00% (77.78%, 100.00%)

86.96% (75.00%, 100.00%)

 < 0.001

ICSI 2PN number

6.00 (4.00, 10.00)

7.00 (4.00, 10.00)

0.251

ICSI 2PN rate (%)

81.82% (62.50%, 93.75%)

75.00% (60.00%, 88.89%)

0.003

Usable embryos

6.00 (3.00, 9.00)

6.00 (3.00, 9.00)

0.887

Usable embryo rate (%)

92.31% (75.00%, 100.00%)

87.50% (66.67%, 100.00%)

 < 0.001

Good-quality embryo

4.00 (2.00, 7.00)

4.00 (2.00, 7.00)

0.320

Good-quality embryo rate (%)

70.59% (50.00%, 90.00%)

69.23% (50.00%, 87.50%)

0.427

Mild/moderate OHSS rate (%)

3.05% (27/884)

2.94% (78/2652)

0.864

Cycle cancellation rate due to OHSS (%)

30.88% (273/884)

27.53% (730/2652)

0.055

  1. Data are displayed as median (interquartile range) for continuous variables because they follow the skewed distribution and % (n) for categorical variables
  2. r-FSH recombinant follicle-stimulating hormone, r-LH recombinant luteinizing hormone, IVF in-vitro fertilization, 2PN 2 pronuclear, ICIS intracytoplasmic sperm injection, OHSS ovarian hyper-stimulation syndrome